Department of Internal Medicine, University of Genoa, Genoa, ItalyInterests: immunodeficiency; autoimmunity; neuro-endocrino-immunology; pharmacogenomics; vaccine and autoimmune diseasesSpecial Issues and Topics in IMR Press journalsSpecial Issue in Role of Vitamin D in Chronic Disease
Department of Clinical and Experimental Medicine, University of Messina, Messina, ItalyInterests: immunosenescence (especially studies on centenarians and inflammaging); immunogenetics, epigenetics and application of machine learning and deep learning in various fields of medicineSpecial Issues and Topics in IMR Press journalsSpecial Issue in Role of Vitamin D in Chronic Disease
Paladin Francesca, PhDSan Martino Polyclinic Hospital (GE) - University of Genoa, Genova, ItalySpecial Issues and Topics in IMR Press journalsSpecial Issue in Role of Vitamin D in Chronic Disease
Dear Colleagues,
Although most cases of COronaVIrus Disease 19 (COVID-19) make a complete recovery, it is now established that some patients experience symptoms that persist or appear after the acute illness. This condition is known as post-COVID syndrome (PCS). The specific pathogenetic mechanisms that underlie PCS and the long term impact at a biological level are still poorly understood. However, the clinical evidence indicates the involvement of chronic inflammation and the predominance of an immune effector phenotype.
In particular, several biomarkers such as IL-6, IL-1β, TNF-α, IFN-γ, IL-10, IL-2, CRP, MCP-1, serum amyloid A and kynurenine pathway metabolites appear to play a central role in the development of PCS. Persistent ACA IgG positivity has also been reported in a patient with PCS, as has increased ANA antibody positivity.
The above observations suggest that Sars-Cov2 infection could determine the de novo development or reactivation of latent autoimmunity through its ability to trigger the release of specific inflammatory mediators.
The aim of this Special Issue is to collect the most recent scientific evidence in support of the immunogenic role of Sars-Cov2 infection and its ability to exacerbate immune-related diseases, also in the context of PCS.
Prof. Giuseppe Murdaca, Prof. Sebastiano Gangemi and Dr. Francesca Paladin
Guest Editors
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
- Open Access Original ResearchSARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal MicrobiomeSilvia Bozza, Emilia Nunzi, Abel Frias-Mazuecos, Giuseppe Pieraccini, ... Claudio CostantiniFront. Biosci. (Landmark Ed) 2024, 29(2), 59; https://doi.org/10.31083/j.fbl2902059(This article belongs to the Special Issue Immunology in COVID-19 Disease)42Downloads109Views
- Open Access ReviewSARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting PossibilitiesRolf MarschalekFront. Biosci. (Landmark Ed) 2023, 28(10), 273; https://doi.org/10.31083/j.fbl2810273(This article belongs to the Special Issue Immunology in COVID-19 Disease)160Downloads451Views